Ionis to hold virtual investor day event

Rhea-AI Summary

Ionis Pharmaceuticals will host a virtual investor day on December 9, 2021, at 11:00 a.m. Eastern Time. The session aims to outline the company's strategy, advancements, and progress in commercializing its leading programs. It will feature discussions on key technological innovations and is expected to last around 2.5 hours. Interested investors can access the webcast through Ionis's official website, with a limited-time replay available.

Ionis has pioneered RNA-targeted therapies for over 30 years, with three marketed medicines and a strong late-stage pipeline.

Positive

• Ionis has a strong late-stage pipeline including neurological and cardiometabolic franchises.
• The virtual investor day provides an opportunity for increased investor engagement and transparency.

Negative

• None.

CARLSBAD, Calif., Dec. 2, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a virtual investor day on Thursday, December 9^th at 11:00 a.m. Eastern Time. The company will provide an overview of its strategy, plans, and progress to bring its most advanced programs to market and achieve commercial success as well as highlight key technology advances. The webcast is expected to last approximately 2.5 hours.

Interested parties may access the webcast at https://www.ionispharma.com/investor-day. A replay will be available for a limited time at the same address.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.

To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-virtual-investor-day-event-301436652.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

When is Ionis Pharmaceuticals' investor day scheduled?

Ionis Pharmaceuticals' virtual investor day is scheduled for December 9, 2021, at 11:00 a.m. Eastern Time.

How long will the Ionis Pharmaceuticals investor day last?

The investor day is expected to last approximately 2.5 hours.

Where can I access the Ionis Pharmaceuticals investor day webcast?

The webcast can be accessed at Ionis Pharmaceuticals' official website.

What topics will be covered in the Ionis Pharmaceuticals investor day?

Topics will include the company's strategy, technological advances, and progress in advancing key programs.

What is the significance of the investor day for Ionis Pharmaceuticals?

The investor day aims to enhance transparency and engagement with investors regarding the company's future plans and advancements.